Hubei Jumpcan Pharmaceutical (SHA:600566) obtained drug registrations from China's medical products regulator for pediatric laxative and mesalazine sustained-release granules.
Pediatric laxative granules are used to relieve constipation in children, while mesalazine is used to treat mild to moderate ulcerative colitis and Crohn's disease, according to a Monday filing with the Shanghai bourse.